Jupiter Neurosciences Expands Brain Health Expertise with Consumer Supplement Line Nugevia

Jupiter Neurosciences Inc. (NASDAQ: JUNS) is expanding its brain health expertise beyond pharmaceuticals with the launch of Nugevia, a direct-to-consumer longevity product line aimed at improving mitochondrial support, mental clarity and beauty from within. The clinical-stage pharmaceutical company, known for developing JOTROL, an enhanced orally administered resveratrol formulation, is now targeting the consumer wellness market with cognitive health as the central focus.

The company expects Nugevia MND, its scientifically formulated supplement designed to protect and enhance cognitive function, to account for about 60% of sales by volume. A Jupiter Neurosciences spokesperson stated, "Brain health is central to Jupiter's DNA as a neuroscience company, and consumer awareness in this area is accelerating rapidly. Our Nugevia MND formulation directly builds on our pharmaceutical expertise in neuroinflammation and CNS function, making it the most natural bridge between our clinical work and consumer wellness line."

This expansion comes amid growing global demand for cognitive support, particularly among aging populations. As people live longer, there is increasing focus on maintaining mental clarity, concentration and overall brain health. The global brain health supplement market is projected to reach approximately $23 billion by 2030, growing at a compound annual growth rate of around 13% between now and then.

All Nugevia products are derived from JOTROL, the company's proprietary resveratrol formulation that delivers about nine times higher absorption than traditional resveratrol and demonstrates proven central nervous system penetration. Jupiter Neurosciences overcame previous limitations with resveratrol by developing a delivery system that makes the compound beneficial. Beyond its antioxidant and anti-inflammatory effects, resveratrol activates PARP-1, an important protein in DNA repair and stress response, and provides additional benefits including improved cardiovascular health, enhanced cognitive function, and antibacterial and antiviral properties against food-borne pathogens.

The company's supplement portfolio includes three main products: Nugevia MND for cognitive health, Nugevia GLO for beauty from within, and Nugevia PWR for energy and performance. What sets these supplements apart from single-ingredient competitors is their precision-engineered "intelligent stacking" of synergistic compounds designed to enhance cellular resilience, support blood-brain barrier delivery and promote system-wide optimization.

Jupiter Neurosciences has leveraged its pharmaceutical background to build credibility in the supplement space. A phase one trial of JOTROL determined the drug was safe and well-tolerated at all dose levels and demonstrated blood plasma levels 8-10-fold higher than naïve resveratrol administered in historical clinical trials. The phase two trial focuses on treating Alzheimer's, Parkinson's and a broad spectrum of CNS and rare diseases. JOTROL has patents in the U.S., Europe, China, Hong Kong and Japan protected through 2036.

To promote its consumer products, the company has enlisted multiple scientists and brand ambassadors including former tennis great Annika Sörenstam, NBA legend Chris Webber, scientist Charbel Moussa and biohacker Jean Fallacar. These representatives span different audiences from elite athletes to entrepreneurs, demonstrating the product's applicability across various lifestyles.

A company spokesperson emphasized the unique positioning of their consumer entry: "Jupiter Neurosciences is first and foremost a clinical-stage biotech company that has spent the past decade developing therapies for complex central nervous system disorders. What makes our entry into the supplement space so unique is that we're coming into it from the clinic, not the other way around. It's a natural evolution of our dual-path strategy: advancing prescription therapies for patients while empowering everyday consumers with credible, evidence-based solutions for healthy aging."